Adjuvant effect of Achyranthes bidentata saponins on specific antibody and cellular response to ovalbumin in mice

Vaccine

Volumn 24, Issue 17, 2006, Pages 3432-3439

  Sun, Hong Xiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Achyranthes bidentatata; Adjuvants; Haemolysis; Saponins

Indexed keywords

ANTIBODY; CONCANAVALIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; LIPOPOLYSACCHARIDE; OVALBUMIN; SAPONIN;

ACHYRANTHES; ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; ERYTHROCYTE; HEMODIALYSIS; HEMOLYSIS; HUMORAL IMMUNITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACHYRANTHES; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; HEMOLYSIS; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED ICR; OVALBUMIN; SAPONINS;

EID: 33645242521     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.02.014     Document Type: Article

References (55)

1. D.T. O'Hagan, M.L. Mackichan, and M. Singh Recent developments in adjuvants for vaccines against infectious diseases Biomol Eng 18 3 2001 69 85
2. J. Aucouturier, L. Dupuis, and V. Ganne Adjuvants designed for veterinary and human vaccines Vaccine 19 2001 2666 2672
3. R. Hunter Overview of vaccine adjuvant: present and future Vaccine 20 sp3 2002 s7 s12
4. E.G. Espinet Nuevo tipo de vacuna antiaftosa a complejo glucovirico Gac Vet 74 1951 1 13
5. C.R. Kensil, U. Patel, M. Lennick, and D.J. Marciani Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex J Immunol 146 2 1991 431 437
6. + cytotoxic T cells by immunization with purified HIV-1 envelope proteins in ISCOMS Nature 344 1990 873 875
7. S. Soltysik, J.Y. Wu, J. Recchia, D.A. Wheeler, M.J. Newman, and R.T. Coughlin Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function Vaccine 13 15 1995 1403 1410
8. C.R. Kensil, and R. Kammer QS-21: a water-soluble triterpene glycoside adjuvant Exp Opin Invest Drugs 7 1998 1475 1482
9. P.O. Livingston, S. Adluri, F. Helling, T.J. Yao, C.R. Kensil, and M.J. Newman Phase I trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma Vaccine 12 1994 1275 1280
10. F. Helling, S. Zhang, A. Shang, S. Adluri, M. Calves, and R. Koganty GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21 Cancer Res 55 1995 2783 2788
11. M. McCaffery, T.J. Yao, L. Willigus, P.O. Livingston, A.N. Houghton, and P.B. Chapman Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside; enhanced immunogenicity when combined with adjuvant Clin Cancer Res 2 1996 679 686
12. K.A. Foon, Q. Sen, L. Hutchins, O.L. Kashala, M. Banerjee, and M. Chakraborty Antibody responses in melanoma patients immunized an anti-idiotype antibody mimicking disialoganglioside GD2 Clin Cancer Res 4 1998 1117 1124
13. + melanoma patients: randomized trial comparing incomplete freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants Clin Cancer Res 8 2002 967 972
14. M.C. Keefer, M. Wolff, G.J. Gorse, B.S. Graham, L. Corey, and M.L. Clements-Mann Safety profile of Phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS vaccine evaluation group AIDS Res Hum Retrov 13 14 1997 1163 1177
15. T.G. Evans, M.J. McElrath, T. Matthews, D. Montefiori, K. Weinhold, and M. Wolff QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans Vaccine 19 2001 2080 2091
16. J.A. Stoute, M. Slaoui, D.G. Heppner, P. Momin, K.E. Kester, and P. Desmons A preliminary evaluation of a recombinant circumsporozoite vaccine against plasmodium falciparum malaria N Engl J Med 336 2 1997 86 91
17. S.J. Cox, P.V. Barnett, P. Dani, and J.S. Salt Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission Vaccine 17 1999 1858 1868
18. D.C. Waite, E.W. Jacobson, F.A. Ennis, R. Edelman, B. White, and R. Kammer Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21 Vaccine 19 28-29 2001 3957 3967
19. D.J. Marciani, J.B. Press, R.C. Reynolds, A.K. Pathak, V. Pathak, and L.E. Gundy Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity Vaccine 18 27 2000 3141 3151
20. D.J. Marciani, A.K. Pathak, R.C. Reynolds, L. Seitz, and R.D. May Altered immunomodulating and toxicological properties of degraded Quillaia saponaria Molina saponins Int Immunopharm 1 2001 813 818
21. Q. Liu, C. Anderson, H. Scaltreto, J. Barbon, and C.R. Kensil QS-21 structure/function studies: effect of acylation on adjuvant activity Vaccine 20 21-22 2002 2808 2815
22. K. Oda, H. Matsuda, T. Murakami, S. Katajama, T. Oghitani, and M. Yoshikawa Adjuvant and hemolytic activities of 47 saponins derived from medicinal and food plants Biol Chem 381 2000 67 74
23. W.R. Santos, V.M. de Lima, E.P. de Souza, R.R. Bernardo, M. Palatnik, and C.B. Palatnik de Sousa Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis Vaccine 21 1-2 2002 30 43
24. D.L. Meng, and X. Li The Research development in the chemical constituents and pharmacological activities of Achyranthes bidentata Bl Chin J Med Chem 11 2 2001 120 124
25. C.C. Li, X.G. Hu, W.X. Zhang, L.W. Xie, H.Y. Zhang, and L. Dong Eosinophils apoptosis, fas mRNA and bcl-2 mRNA expressions in asthma model of young rat and effects of achyranthes bidentata polysaccharides Chin J Pediatr 41 9 2003 657 660
26. X.M. Chen, Y.J. Xu, and G.Y. Tian Physical-chemical properties and structure elucidation of abPS isolated from the root of Achyranthes bidentata Acta Pharm Sin 40 1 2005 32 35
27. Y.J. Yuan, Y. Cui, Y. Yu, and Y.H. Yong Different mechanisms mediate the exciting effect about Achyranthes bidentata on the spike activity of the uterine smooth muscle in virgin rats Chin J Vet Sci Technol 32 12 2002 8 12
28. W.X. Zhang, S.L. Yang, X.S. Zhang, D.M. Xue, S.L. Zhang, and J.D. Wei The relationship between anti-implantation of Achyranthes bidentata Bl. and mast cell in the uterus Chin J Immunol 18 7 2002 492 495
29. Y.F. Wang, Q.D. Wang, C.J. Liu, J.H. Jiang, W.X. Sun, and W. Xia Antitumor activity of the crude saponins from Achyranthes bidentata J Henan Med Univ 32 4 1997 4 6
30. T.L. Lu, C.Q. Mao, L.I. Zhang, and W. Xu The research on analgestic and anti-inflammatory action of different processed products of Achyranthes bidentata J Chin Med Mat 20 10 1997 507 509
31. Y.C. Lin, C.R. Wu, C.J. Lin, and M.T. Hsieh The ameliorating effects of cognition-enhancing Chinese herbs on scopolamine- and MK-801-induced amnesia in rats Am J Chin Med 31 4 2003 543 549
32. H. Luo, F. Gu, and X. Li Inhibiting effect of ethanol extract from Achyranthes bidentata on Aβ 42 aggregation J Chin Med Mat 26 6 2003 412 415
33. H.B. Deng, D.P. Cui, J.M. Jiang, Y.C. Feng, N.S. Cai, and D.D. Li Inhibiting effects of Achyranthes bidentata polysaccharide and Lycium barbarum polysaccharide on nonenzyme glycation in d-galactose induced mouse aging model Biomed Environ Sci 16 3 2003 267 275
34. Y.H. Chu, and Y.Q. Guo Experimental study on antisenence effect of Achyranthes Bidentata Clin Med Chin 90 2003 8797 8798
35. C.K. Gao Studies on the preventive and curative effects of Achyranthes bidentata on osteoporotis induced by retioic acid in rats Prim J Chin Mat Med 15 2 2001 9 11
36. X.J. Wang, and L.Z. Zhu Studies on the saponin constituents of Niu Qi (Achyrathes Bidentata) J Fourth Mil Med Univ 17 6 1996 427 430
37. A.C. Mitaine-Offer, A. Marouf, C. Pizza, T.C. Khanh, B. Chauffert, and M.A. Lacaille-Dubois Bidentatoside I, a new triterpene saponin from Achyranthes bidentata J Nat Prod 64 2 2001 243 245
38. A.C. Mitaine-Offer, A. Marouf, B. Hanquet, N. Birlirakis, and M.A. Lacaille-Dubois Two triterpene saponins from Achyranthes bidentata Chem Pharm Bull 49 11 2001 1492 1494
39. D.L. Meng, X. Li, Y.H. Xiong, and J.H. Wang Study on the chemical constituents of Achyranthes bidentata Bl J Shenyang Pharm Univ 19 1 2002 27 30
40. Y. Liang, K.Y. Fang, B.J. Guo, G.H. Liang, and Y.P. Song Studies on triterpene saponin from Achyranthes bientata Bl. by electrospray ionization tandem mass spectrometry J Chin Mass Spec Soc 25 Suppl. 2004 143 144
41. G.S. Wang, X.P. Zhou, X.H. Yang, and J.D. Xu Study on the acidic triterpenoid saponins of Achyranthes bientata Bl Chin J Med Chem 14 1 2004 40 41
42. A.M. Hu, Z.M. Bi, and P. Li Studies on the Chemical constituents of Achyranthes bidentata Jiangsu Pharm Clin Res 12 3 2004 18 19
43. T. Wang, S.Y. Cui, Y.R. Suo, and R.H. Lu Studies on water-soluble chemical constituents in root of Achyranthes bidentata China J Chin Mat Med 29 7 2004 649 652
44. J.X. Li, T. Hareyama, Y. Tezuka, Y. Zhang, T. Miyahara, and S. Kadota Five new oleanolic acid glycosides from Achyranthes bidentata with inhibitory activity on osteoclast formation Planta Med 71 7 2005 673 679
45. T.T. Zhu, H. Liang, Y.Y. Zhao, and B. Wang Isolation and structure identification of C-25 epimers of inokosterone from Achyranthes bidentata Blume Acta Pharm Sin 39 11 2004 913 916
46. D.L. Meng, X. Li, J.H. Wang, and W. Li A new phytosterone from Achyranthes bidentata Bl J Asian Nat Prod Res 7 2 2005 181 184
47. N. Stefan, T. Ngugen, and Z. Valcho Flavonoids from Achyranthes bidentata Bl Acta Hoytic 1996 426
48. G. Bisht, and H. Sandhu Chemical constituents and antimicrobial activity of Achyranthes Bidentata J Indian Chem Soc 67 12 1990 1002 1008
49. C.K. Gao, J. Gao, R.L. Ma, X.X. Xu, P. Huang, and S.D. Ni Research on analgesic and anti-inflammatory and invigorate circulation effects of total saponins of Achyranthes Anhui Med Pharm J 7 4 2003 248 249
50. P.X. Zhao, S.W. Wang, and J.B. Wang Study on extraction processes of oleanolic acid from Radix Achyranthes Bidentatae Shanxi J Tradit Chin Med 26 10 2005 1099 10101
51. H.X. Sun, F. Qin, and Y.P. Ye Relationship between haemolytic and adjuvant activity and structure of protopanaxadiol-type saponins from the roots of Panax notoginseng Vaccine 23 48-49 2005 5533 5542
52. H.X. Sun, Z.G. Yang, and Y.P. Ye Structure and biological activity of protopanaxatriol-type saponins from the roots of Panax notoginseng Int Immunopharmacol 6 1 2006 14 25
53. M. Takechi, and Y. Tanaka Haemolytic time course differences between steroid and triterpenoid saponins Planta Med 61 1995 76 77
54. W.R. Santos, R.R. Bernardo, L.M. Pecanha, M. Palatnik, J.P. Parente, and C.B. Palatnik de Sousa Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani Vaccine 15 1997 1024 1029
55. B.P. Silva, J.B. Soares, E.P. Souza, M. Palatnik, C.B. Sousa, and J.P. Parente Pulcherrimasaponin, from the leaves of Calliandrapulcherrima, as adjuvant for immunization in the murine model of visceral leishmaniasis Vaccine 23 2005 1061 1071